Despite insufficient HNSCC cell line data to test the interaction between TP53 and PAK2 in determining PAK‐5339 sensitivity, these findings support considering the status of both gene loci in prediction of PAK2 inhibitor responses. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.